CNMD
CONMED CorpCompany Information
- Company Name
- CONMED Corp
- CIK
- CIK0000816956
- Category
- Large accelerated filer
- Ticker: Exchange
- CNMD: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- CNMD
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-05-13
- Last sale
- 2025-11-21
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 10,612
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 33,600,206
- Shares outstanding
- 30,069,000
- Ownership
- 111.74%
Earnings Market Reaction
- Filing date
- 2026-07-29
- Price on filing date
- —
- 1-month reaction
- 18.19%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 37 | 41 | 39 | 34 | 35 | 24 | 38 | 29 | 34 | 24 | 31 | ||||||
| Accounts Receivable Net Current | 240 | 248 | 225 | 234 | 221 | 238 | 231 | 239 | 241 | 242 | 230 | ||||||
| Inventory Net | 360 | 356 | 364 | 362 | 355 | 347 | 343 | 322 | 322 | 318 | 326 | ||||||
| Prepaid Expense And Other Assets Current | 38 | 29 | 34 | 27 | 28 | 31 | 29 | 33 | 38 | 31 | 39 | ||||||
| Assets Current | 676 | 673 | 662 | 658 | 639 | 640 | 641 | 624 | 636 | 616 | 626 | ||||||
| Property Plant And Equipment Net | 110 | 113 | 112 | 117 | 116 | 116 | 117 | 117 | 118 | 121 | 120 | ||||||
| Deferred Income Tax Assets Net | - | 13 | - | - | - | 11 | - | - | - | 11 | - | ||||||
| Goodwill | 797 | 807 | 807 | 807 | 806 | 805 | 807 | 806 | 806 | 807 | 815 | ||||||
| Intangible Assets Net Excluding Goodwill | 564 | 582 | 593 | 602 | 610 | 618 | 626 | 633 | 641 | 649 | 657 | ||||||
| Other Assets Noncurrent | 153 | 137 | 148 | 145 | 127 | 116 | 125 | 105 | 108 | 96 | 107 | ||||||
| Assets | 2,300 | 2,326 | 2,322 | 2,328 | 2,298 | 2,306 | 2,316 | 2,286 | 2,309 | 2,300 | 2,326 | ||||||
Liabilities Current | |||||||||||||||||
| Long Term Debt And Capital Lease Obligations Current | 177 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 71 | ||||||
| Accounts Payable Current | 101 | 94 | 107 | 101 | 96 | 102 | 105 | 101 | 102 | 88 | 82 | ||||||
| Employee Related Liabilities Current | 70 | 82 | 76 | 68 | 58 | 65 | 61 | 55 | 50 | 70 | 60 | ||||||
| Other Liabilities Current | 107 | 139 | 131 | 125 | 129 | 110 | 116 | 109 | 139 | 152 | 163 | ||||||
| Liabilities Current | 455 | 315 | 315 | 295 | 283 | 278 | 282 | 266 | 291 | 311 | 376 | ||||||
| Long Term Debt And Capital Lease Obligations | 657 | 834 | 853 | 881 | 891 | 905 | 940 | 965 | 990 | 973 | 942 | ||||||
| Deferred Income Tax Liabilities Net | 85 | 80 | 75 | 70 | 70 | 74 | 66 | 65 | 64 | 61 | 67 | ||||||
| Other Liabilities Noncurrent | 62 | 64 | 72 | 80 | 76 | 86 | 95 | 107 | 109 | 121 | 144 | ||||||
| Liabilities | 1,259 | 1,293 | 1,314 | 1,326 | 1,320 | 1,344 | 1,383 | 1,404 | 1,455 | 1,466 | 1,529 | ||||||
Stockholders Equity | |||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 513 | 503 | 499 | 494 | 489 | 477 | 471 | 465 | 458 | 447 | 440 | ||||||
| Retained Earnings Accumulated Deficit | 626 | 589 | 572 | 575 | 560 | 560 | 533 | 490 | 466 | 453 | 426 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -43 | -46 | -49 | -53 | -57 | -59 | -55 | -54 | -50 | -50 | -54 | ||||||
| Treasury Stock Value | - | -13 | - | - | - | -16 | - | - | - | -15 | - | ||||||
| Treasury Stock Common Value | -55 | - | -14 | -14 | -15 | - | -16 | -19 | -20 | - | -15 | ||||||
| Stockholders Equity | 1,041 | 1,033 | 1,008 | 1,003 | 978 | 963 | 933 | 882 | 855 | 834 | 796 | ||||||
| Liabilities And Stockholders Equity | 2,300 | 2,326 | 2,322 | 2,328 | 2,298 | 2,306 | 2,316 | 2,286 | 2,309 | 2,300 | 2,326 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | 6 | - | - | - | 6 | - | - | - | 6 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | - | 0 | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | ||||||
| Treasury Stock Common Shares | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCONMED Corp (CNMD) — SEC Financial Statements & Analysis
CONMED Corp (CNMD) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. CONMED Corp trades on NYSE as: CNMD. CONMED Corp (CNMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29. Based on that filing, CONMED Corp carries a market cap of $984.16M, a P/E ratio of 15.36x, a P/B ratio of 0.95x, a P/S ratio of 0.70x, an enterprise value of $1.78B, and an EV/EBITDA multiple of 12.35x. On profitability, it posts a gross margin of 55.13%, an operating margin of 8.81%, a net margin of 4.59%, a Return on Equity (ROE) of 6.35%, a Return on Assets (ROA) of 2.79%, and a Return on Invested Capital (ROIC) of 4.47%. Per share, it reports EPS of $2.13, diluted EPS of $2.13, free cash flow per share of $5.25, and a dividend per share of $0.62. Over the trailing year, it posted revenue growth of 6.15% year-over-year, net income growth of -46.03% year-over-year, and EPS growth of -44.41% year-over-year. On the balance sheet, it maintains a current ratio of 1.48x, a quick ratio of 0.61x, working capital of $220.27M, a debt-to-equity ratio of 1.21x, a debt ratio of 0.55, an interest coverage ratio of 4.01x, free cash flow of $157.87M (TTM), and net debt of $796.92M. Figures sourced from SEC EDGAR.
- Market Cap
- $984.16M
- P/E TTM
- 15.36x
- EPS TTM
- $2.13
- P/B TTM
- 0.95x
- ROE TTM
- 6.35%
- ROA TTM
- 2.79%
- Debt To Equity
- 1.21x
- Free Cash Flow TTM
- $157.87M
- Net Revenue TTM Growth 1Y
- 6.15%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CONMED Corp in?
CONMED Corp (CNMD) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does CNMD trade on?
CONMED Corp (CNMD) trades on the NYSE.
Where is CONMED Corp incorporated?
CONMED Corp is incorporated in DE.
When was CONMED Corp (CNMD)'s most recent SEC filing?
CONMED Corp (CNMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-07-29.
What is CNMD's market cap?
CONMED Corp (CNMD) has a market capitalization of $984.16M as of 2026-06-30.
What is CNMD's P/E ratio?
CONMED Corp (CNMD)'s trailing twelve month P/E ratio is 15.36x as of 2026-06-30.
What is CNMD's EPS (earnings per share)?
CONMED Corp (CNMD)'s trailing twelve month EPS is $2.13 as of 2026-06-30.
What is CNMD's ROE (return on equity)?
CONMED Corp (CNMD)'s trailing twelve month Return on Equity (ROE) is 6.35% as of 2026-06-30.
What is CNMD's ROA (return on assets)?
CONMED Corp (CNMD)'s trailing twelve month Return on Assets (ROA) is 2.79% as of 2026-06-30.
What is CNMD's ROIC (return on invested capital)?
CONMED Corp (CNMD)'s trailing twelve month Return on Invested Capital (ROIC) is 4.47% as of 2026-06-30.
What is CNMD's EV/EBITDA?
CONMED Corp (CNMD)'s trailing twelve month EV/EBITDA is 12.35x as of 2026-06-30.